{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:32:38Z","timestamp":1790317958364,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Robber's Research Award","award":["17A293059836"],"award-info":[{"award-number":["17A293059836"]}]},{"DOI":"10.13039\/100008901","name":"College of Pharmacy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AR063104"],"award-info":[{"award-number":["AR063104"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000980","name":"Arthritis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000980","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Research Grant"},{"DOI":"10.13039\/100007588","name":"Washington State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.taap.2017.05.016","type":"journal-article","created":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T21:00:40Z","timestamp":1495227640000},"page":"112-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"C","title":["Molecular insights into the differences in anti-inflammatory activities of green tea catechins on IL-1\u03b2 signaling in rheumatoid arthritis synovial fibroblasts"],"prefix":"10.1016","volume":"329","author":[{"given":"Sabrina","family":"Fechtner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Chourasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salahuddin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.taap.2017.05.016_bb0005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.12691\/ijcd-3-4-8","article-title":"The world incidence and prevalence of autoimmune diseases is increasing","volume":"3","author":"Lerner","year":"2015","journal-title":"Int. J. Celiac Dis."},{"issue":"12","key":"10.1016\/j.taap.2017.05.016_bb0010","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bcp.2010.06.020","article-title":"The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling","volume":"80","author":"Flannery","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.taap.2017.05.016_bb0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.smim.2013.10.023","article-title":"The interleukin-1 receptor family","volume":"25","author":"Boraschi","year":"2013","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.taap.2017.05.016_bb0020","series-title":"Kelley's Textbook of Rheumatology","article-title":"Prostanoid biology and its therapeutic targeting","author":"Crofford","year":"2013"},{"key":"10.1016\/j.taap.2017.05.016_bb0025","article-title":"NSAIDs and cardiovascular risk","author":"Marsico","year":"2016","journal-title":"J. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.taap.2017.05.016_bb0030","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1017\/S0029665110001564","article-title":"Fish oil and rheumatoid arthritis: past, present and future","volume":"69","author":"James","year":"2010","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.taap.2017.05.016_bb0035","doi-asserted-by":"crossref","first-page":"505842","DOI":"10.1155\/2012\/505842","article-title":"A synoviocyte model for osteoarthritis and rheumatoid arthritis: response to Ibuprofen, betamethasone, and ginger extract-a cross-sectional in vitro study","volume":"2012","author":"Ribel-Madsen","year":"2012","journal-title":"Arthritis"},{"issue":"2","key":"10.1016\/j.taap.2017.05.016_bb0040","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar2982","article-title":"Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise","volume":"12","author":"Ahmed","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"25\u201326","key":"10.1016\/j.taap.2017.05.016_bb0045","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.lfs.2010.04.013","article-title":"Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis","volume":"86","author":"Singh","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2017.05.016_bb0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.biopha.2015.12.013","article-title":"Protective role of epigallocatechin-3-gallate in health and disease: a perspective","volume":"78","author":"Chowdhury","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2017.05.016_bb0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpba.2016.03.048","article-title":"Development of a UFLC-MS\/MS method for the simultaneous determination of seven tea catechins in rat plasma and its application to a pharmacokinetic study after administration of green tea extract","volume":"125","author":"Huo","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"8","key":"10.1016\/j.taap.2017.05.016_bb0060","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/art.22023","article-title":"Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts","volume":"54","author":"Ahmed","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"38","key":"10.1016\/j.taap.2017.05.016_bb0065","doi-asserted-by":"crossref","first-page":"14692","DOI":"10.1073\/pnas.0802675105","article-title":"Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production","volume":"105","author":"Ahmed","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.taap.2017.05.016_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/art.39447","article-title":"Regulation of TAK1 activation by epigallocatechin-3-gallate in RA synovial fibroblasts: Suppression of K63-linked autoubiquitination of TRAF6","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.taap.2017.05.016_bb0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1021\/cb3005897","article-title":"Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-oxozeaenol","volume":"8","author":"Wu","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.taap.2017.05.016_bb0080","doi-asserted-by":"crossref","first-page":"18485","DOI":"10.1074\/jbc.M207453200","article-title":"A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase","author":"Ninomiya-Tsuji","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.taap.2017.05.016_bb0085","first-page":"89","article-title":"Concentrations of prostaglandins D2, E2, F2 alpha, 6-keto-F1 alpha and thromboxane B2 in synovial fluid from patients with inflammatory joint disorders and osteoarthritis","volume":"43","author":"Egg","year":"1984","journal-title":"Z. Rheumatol."},{"issue":"12","key":"10.1016\/j.taap.2017.05.016_bb0090","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/1529-0131(200012)43:12<2687::AID-ANR8>3.0.CO;2-9","article-title":"The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis","volume":"43","author":"Myers","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.taap.2017.05.016_bb0095","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0891-5849(02)01004-3","article-title":"Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes","volume":"33","author":"Ahmed","year":"2002","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.taap.2017.05.016_bb0100","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00296-009-1128-8","article-title":"Effects of (\u2212)-epigallocatechin-3-gallate on cyclooxygenase 2, PGE(2), and IL-8 expression induced by IL-1beta in human synovial fibroblasts","volume":"30","author":"Huang","year":"2010","journal-title":"Rheumatol. Int."},{"issue":"9149","key":"10.1016\/j.taap.2017.05.016_bb0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(98)12154-2","article-title":"COX-2 inhibitors","volume":"353","author":"Hawkey","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2017.05.016_bb0110","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kew301","article-title":"Transforming growth factor beta activated kinase 1: a potential therapeutic target for rheumatic diseases","author":"Fechtner","year":"2016","journal-title":"Rheumatology"},{"issue":"13","key":"10.1016\/j.taap.2017.05.016_bb0115","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1038\/sj.onc.1209227","article-title":"The green tea catechins, (\u2212)-epigallocatechin-3-gallate (EGCG) and (\u2212)- epicatechin-3-gallate (ECG), inhibit HGF\/Met signaling in immortalized and tumorigenic breast epithelial cells","volume":"25","author":"Bigelow","year":"2006","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.taap.2017.05.016_bb0120","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3390\/nu4111679","article-title":"Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea","volume":"4","author":"Du","year":"2012","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.taap.2017.05.016_bb0125","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1096\/fj.01-0799fje","article-title":"Inhibition of the PDGF beta-receptor tyrosine phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins","volume":"16","author":"Sachinidis","year":"2002","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.taap.2017.05.016_bb0130","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1158\/1078-0432.CCR-04-2549","article-title":"Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of polyphenon E in healthy individuals","volume":"11","author":"Chow","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.taap.2017.05.016_bb0135","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1207\/S15327914NC4502_13","article-title":"Catechin content of 18 teas and a green tea extract supplement correlates with the antioxidant capacity","volume":"45","author":"Henning","year":"2003","journal-title":"Nutr. Cancer"},{"issue":"3","key":"10.1016\/j.taap.2017.05.016_bb0140","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1021\/jf010153l","article-title":"Total phenol, catechin, and caffeine contents of teas commonly consumed in the United kingdom","volume":"50","author":"Khokhar","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.taap.2017.05.016_bb0145","series-title":"LigPrep, version 3.4","author":"Schr\u00f6dinger Release 2015\u20132","year":"2015"},{"key":"10.1016\/j.taap.2017.05.016_bb0155","series-title":"Desmond Molecular Dynamics System, version 4.2","author":"Schr\u00f6dinger Release 2015\u20132","year":"2015"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17302107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17302107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T04:34:51Z","timestamp":1575520491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X17302107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":30,"alternative-id":["S0041008X17302107"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2017.05.016","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular insights into the differences in anti-inflammatory activities of green tea catechins on IL-1\u03b2 signaling in rheumatoid arthritis synovial fibroblasts","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2017.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}